These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8840306)

  • 21. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1beta, TNF-alpha, TGF-beta, and bFGF expression in bone biopsies before and after parathyroidectomy.
    Santos FR; Moysés RM; Montenegro FL; Jorgetti V; Noronha IL
    Kidney Int; 2003 Mar; 63(3):899-907. PubMed ID: 12631070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
    Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
    J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Bianchi ML; Colantonio G; Campanini F; Rossi R; Valenti G; Ortolani S; Buccianti G
    Nephrol Dial Transplant; 1994; 9(11):1595-9. PubMed ID: 7870349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
    Khajehdehi P; Taheri S
    J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.
    Annenkov AY; Strokov AG; Baranova FS
    Clin Exp Immunol; 1992 Oct; 90(1):49-55. PubMed ID: 1395100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration.
    Perez-Mijares R; Gomez-Fernandez P; Almaraz-Jimenez M; Ramos-Diaz M; Rivero-Bohorquez J
    Am J Nephrol; 1993; 13(2):149-54. PubMed ID: 8342582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density.
    Türk S; Akbulut M; Yildiz A; Gürbilek M; Gönen S; Tombul Z; Yeksan M
    Nephron; 2002 Feb; 90(2):188-94. PubMed ID: 11818704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
    Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
    Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'Pulse' oral calcitriol in uraemic patients: rapid modification of parathyroid response to calcium.
    Kwan JT; Almond MK; Beer JC; Noonan K; Evans SJ; Cunningham J
    Nephrol Dial Transplant; 1992; 7(8):829-34. PubMed ID: 1325616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine production by peripheral blood cells in postmenopausal osteoporosis.
    Zarrabeitia MT; Riancho JA; Amado JA; Napal J; Gonzalez-Macias J
    Bone Miner; 1991 Aug; 14(2):161-7. PubMed ID: 1912764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcitriol pulse therapy for severe hyperparathyroidism or calcium salts as phosphate binders in renal dialysis patients?
    Gonella M; Calabrese G; Aleo AG; Vagelli G; Deambrogio P
    Nephron; 1995; 71(3):350-3. PubMed ID: 8569985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3.
    Allegra V; Luisetto G; Mengozzi G; Martimbianco L; Vasile A
    Nephron; 1994; 68(1):41-7. PubMed ID: 7991039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: a comparative study.
    Schaefer K; Scheer J; Asmus G; Umlauf E; Hagemann J; von Herrath D
    Nephrol Dial Transplant; 1991; 6(3):170-5. PubMed ID: 1866045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
    Delmez JA; Kelber J; Norwood KY; Giles KS; Slatopolsky E
    Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autotransplantation of parathyroid glands into subcutaneous forearm tissue for renal hyperparathyroidism.
    Chou FF; Chan HM; Huang TJ; Lee CH; Hsu KT
    Surgery; 1998 Jul; 124(1):1-5. PubMed ID: 9663244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients With Low Bone Mass.
    Chen CL; Chen NC; Liang HL; Hsu CY; Chou KJ; Fang HC; Lee PT
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2784-92. PubMed ID: 25955225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.